Progress in Cardiac Resynchronisation Therapy and Optimisation

J Cardiovasc Dev Dis. 2023 Oct 17;10(10):428. doi: 10.3390/jcdd10100428.

Abstract

Cardiac resynchronisation therapy (CRT) has become the cornerstone of heart failure (HF) treatment. Despite the obvious benefit from this therapy, an estimated 30% of CRT patients do not respond ("non-responders"). The cause of "non-response" is multi-factorial and includes suboptimal device settings. To optimise CRT settings, echocardiography has been considered the gold standard but has limitations: it is user dependent and consumes time and resources. CRT proprietary algorithms have been developed to perform device optimisation efficiently and with limited resources. In this review, we discuss CRT optimisation including the various adopted proprietary algorithms and conduction system pacing.

Keywords: CRT; device therapy; heart failure; pacemaker.

Publication types

  • Review

Grants and funding

Zaki Akhtar received funding for a research fellowship from Abbott Medical.